Management - Page 15 of 50 - Express Pharma

Dermatology space to benefit most from five potential blockbusters

Let’s move this story forward

Global dermatology market set to benefit extensively from pipeline biologics

Long-acting therapies could transform HIV treatment by boosting compliance

NASH market will increase more than 40 fold by 2026

Asia-Pacific asthma market will hit $6 billion by 2023

First-in-class innovation a key strategy for pharma companies in a harsh market environment: GBI Research

Haematological cancers pharma pipeline one of the strongest within oncology: GBI Research

Global immunology market to surpass $75 bn by 2022 despite patent expirations

Growth hormone deficiency market to grow steadily, surpassing $2 bn by 2026